BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25221363)

  • 21. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas.
    Saito M; Imada H; Suzuki T; Sata N; Yasuda Y; Maetani I; Fukushima N
    Ann Diagn Pathol; 2015 Oct; 19(5):347-52. PubMed ID: 26265194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtyping of IPMN.
    Furukawa T
    Methods Mol Biol; 2019; 1882():1-8. PubMed ID: 30378039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features.
    Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y
    Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.
    Nishigami T; Onodera M; Torii I; Sato A; Tao LH; Kushima R; Kakuno A; Kishimoto M; Katsuyama E; Fujimori T; Hirano H; Satake M; Kuroda N; Nishiguchi S; Fujimoto J; Tsujimura T
    Pancreas; 2009 Jul; 38(5):558-64. PubMed ID: 19287335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
    Sclabas GM; Barton JG; Smyrk TC; Barrett DA; Khan S; Kendrick ML; Reid-Lombardo KM; Donohue JH; Nagorney DM; Que FG
    J Am Coll Surg; 2012 Jan; 214(1):27-32. PubMed ID: 22112419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
    J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.
    Mohri D; Asaoka Y; Ijichi H; Miyabayashi K; Kudo Y; Seto M; Ohta M; Tada M; Tanaka Y; Ikenoue T; Tateishi K; Isayama H; Kanai F; Fukushima N; Tada M; Kawabe T; Omata M; Koike K
    J Gastroenterol; 2012 Feb; 47(2):203-13. PubMed ID: 22041919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
    Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
    JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Kayashima T; Hayashi A; Nakata K; Oda Y; Taguchi T; Tsuneyoshi M; Tanaka M; Oda Y
    Pathobiology; 2012; 79(2):107-14. PubMed ID: 22286087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
    Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
    Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of intestinal-type mucin (MUC2) in intraductal papillary mucinous neoplasms coexisting with extrapancreatic gastrointestinal cancers.
    Lee SY; Choi DW; Jang KT; Lee KT; Choi SH; Heo JS; Lee JK; Paik SW; Rhee JC
    Pancreas; 2006 Mar; 32(2):186-9. PubMed ID: 16552339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.
    Kwak HA; Liu X; Allende DS; Pai RK; Hart J; Xiao SY
    Mod Pathol; 2016 Sep; 29(9):977-84. PubMed ID: 27198568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.
    Kitazono I; Higashi M; Kitamoto S; Yokoyama S; Horinouchi M; Osako M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
    Pancreas; 2013 Oct; 42(7):1120-8. PubMed ID: 23921963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal neoplasms of the pancreas.
    Klöppel G; Basturk O; Schlitter AM; Konukiewitz B; Esposito I
    Semin Diagn Pathol; 2014 Nov; 31(6):452-466. PubMed ID: 25282472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas.
    Okada K; Hirabayashi K; Imaizumi T; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Biomed Res; 2010 Feb; 31(1):13-9. PubMed ID: 20203415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current understanding of precursors to pancreatic cancer.
    Takaori K
    J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.
    Mattiolo P; Hong SM; Paolino G; Rusev BC; Marchegiani G; Salvia R; Andrianello S; Capelli P; Piccoli P; Parolini C; Scarpa A; Lawlor RT; Luchini C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
    Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal tubular adenoma of the pancreas as a possible rare variant of gastric-type intraductal papillary mucinous neoplasm: a report of two cases.
    Teng X; Xue D; Lai M
    Anal Quant Cytopathol Histpathol; 2012 Dec; 34(6):325-30. PubMed ID: 23304818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.